AC Immune SA (ACIU) stock
ACIUNasdaqPharmaceutical PreparationsFiscal year ends December 31
$2.11+0.02 (+0.96%)
Close on Nov 17, 2026Market cap $214.68MP/E –Yield –
AC Immune price to sales ratio
The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.
AC Immune's price to sales ratio was 52.2× on Nov 11, 2026, against 8.8× a year earlier. Over the last 5 years it ranged from 2.9× to 89.2×, with a median of 25.5×.
Price to Sales Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 52.2× | +43.1 |
| 2025 | Dec 31, 2025 | 9.1× | −4.9 |
| 2024 | Dec 31, 2024 | 14.0× | −75.2 |
| 2023 | Dec 29, 2023 | 89.2× | +70.1 |
| 2022 | Jan 31, 2022 | 19.2× | −1.9 |
| 2021 | Dec 31, 2021 | 21.1× | +18.2 |
| 2020 | Dec 31, 2020 | 2.9× | −70.8 |
| 2019 | Dec 31, 2019 | 73.8× | +48.9 |
| 2018 | Dec 31, 2018 | 24.9× | −2.0 |
| 2017 | Dec 29, 2017 | 26.9× | +11.4 |
| 2016 | Dec 30, 2016 | 15.5× | – |
See a number that looks wrong?